Abstract
The global impact of human immunodeficiency virus and acquired immunodeficiency syndrome (HIV/AIDS) is increasing and traditional preventative ‘safe sex’ strategies do not seem to be slowing the spread of this virus. With an efficacious vaccine at least a decade away, the only strategy to avoid the ever-increasing cost of highly active antiretroviral therapy (HAART) is to develop new methods that prevent virus transmission. Microbicides are topicallyapplied molecules that disrupt the HIV cycle and block infection. This review discusses the current state of the art in microbicide development, looking at the most clinically advanced microbicides and those at earlier development stages based on their mechanisms of action. The socioeconomic impact of microbicide use is also considered, as this will determine whether microbicides are taken up and used consistently by the target population.
Keywords: Microbicide, HIV/AIDS, surfactant, antiretroviral, combination microbicide, umbrella compound, developing country, socioeconomic impact
Current Pharmaceutical Design
Title: Can Microbicides Turn the Tide Against HIV?
Volume: 16 Issue: 4
Author(s): Koreen Ramessar, Maite Sabalza, Bruna Miralpeix, Teresa Capell and Paul Christou
Affiliation:
Keywords: Microbicide, HIV/AIDS, surfactant, antiretroviral, combination microbicide, umbrella compound, developing country, socioeconomic impact
Abstract: The global impact of human immunodeficiency virus and acquired immunodeficiency syndrome (HIV/AIDS) is increasing and traditional preventative ‘safe sex’ strategies do not seem to be slowing the spread of this virus. With an efficacious vaccine at least a decade away, the only strategy to avoid the ever-increasing cost of highly active antiretroviral therapy (HAART) is to develop new methods that prevent virus transmission. Microbicides are topicallyapplied molecules that disrupt the HIV cycle and block infection. This review discusses the current state of the art in microbicide development, looking at the most clinically advanced microbicides and those at earlier development stages based on their mechanisms of action. The socioeconomic impact of microbicide use is also considered, as this will determine whether microbicides are taken up and used consistently by the target population.
Export Options
About this article
Cite this article as:
Ramessar Koreen, Sabalza Maite, Miralpeix Bruna, Capell Teresa and Christou Paul, Can Microbicides Turn the Tide Against HIV?, Current Pharmaceutical Design 2010; 16 (4) . https://dx.doi.org/10.2174/138161210790232202
DOI https://dx.doi.org/10.2174/138161210790232202 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
subject Index To Volume 1
Current Medicinal Chemistry - Anti-Inflammatory & Anti-Allergy Agents Assessment of Acute Coronary Syndromes: Focus on Novel Biomarkers
Current Medicinal Chemistry 4-Thiophenoxy-N-(3,4,5-Trialkoxyphenyl)Pyrimidine-2-Amines as Potent and Selective Inhibitors of the T-Cell Tyrosine Kinase p56lck
Current Medicinal Chemistry Biologic Aspects of Thrombopoietin and the Development of Novel Thrombopoietic Agents for Clinical Use
Current Drug Discovery Technologies Transglutaminases as Targets for Pharmacological Inhibition
Mini-Reviews in Medicinal Chemistry Expression and Role of the Calcium-Sensing Receptor in the Blood Vessel Wall
Current Pharmaceutical Biotechnology Astrocytes: Targets for Neuroprotection in Stroke
Central Nervous System Agents in Medicinal Chemistry Current & Future Therapies of Erectile Dysfunction in Neurological Disorders
Recent Patents on CNS Drug Discovery (Discontinued) Humoral and Mechanical Cross-Talk in the Vasculature: Perspectives in Vascular Disease
Vascular Disease Prevention (Discontinued) Evaluating Protein-protein Interaction (PPI) Networks for Diseases Pathway, Target Discovery, and Drug-design Using `In silico Pharmacology`
Current Protein & Peptide Science Non-glycemic Adverse Effects of Insulin
Current Diabetes Reviews Proteomic Analysis of Peanut Seed Storage Proteins and Genetic Variation in a Potential Peanut Allergen
Protein & Peptide Letters Experimental Therapy for Lung Cancer: Umbilical Cord-Derived Mesenchymal Stem Cell-Mediated Interleukin-24 Delivery
Current Cancer Drug Targets Editorial [Hot Topic: Vasoactive Intestinal Peptide (VIP): Historic Perspective and Future Potential]
Endocrine, Metabolic & Immune Disorders - Drug Targets Novel Drug Delivery System for Cancer Management: A Review
Current Cancer Therapy Reviews Exploring Mechanisms of MicroRNA Downregulation in Cancer
MicroRNA Inflammasome, Inflammation and Cancer: An Interrelated Pathobiological Triad
Current Drug Targets Conventional and Gene Therapy Strategies for the Treatment of Brain Tumors
Current Medicinal Chemistry Natural Active Compounds from Plant Food and Chinese Herbal Medicine for Nonalcoholic Fatty Liver Disease
Current Pharmaceutical Design The Dialogue Between Endothelial Cells and Monocytes/Macrophages in Vascular Syndromes
Current Pharmaceutical Design